Lipe & Dalton Medtronic PLC Transaction History

Lipe & Dalton

$185 Million
Q2 2025

A detailed history of Lipe & Dalton transactions in Medtronic PLC stock. As of the latest transaction made, Lipe & Dalton holds 11,288 shares of MDT stock, worth $1.09 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

11,288

Previous 12,138 7.0%

Holding current value

$1.09 Million

Previous $1.09 Million 9.81%

% of portfolio

0.53%

Previous 0.61%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$80.68 - $88.86 $68,578 - $75,531	-850 Reduced 7.0%	11,288 $984,000
Q1 2025 May 05, 2025	SELL	$79.84 - $94.5 $88,622 - $104,895	-1,110 Reduced 8.38%	12,138 $1.09 Million
Q4 2024 Feb 03, 2025	SELL	$79.61 - $92.24 $37,575 - $43,537	-472 Reduced 3.44%	13,248 $1.06 Million
Q3 2024 Nov 04, 2024	SELL	$76.84 - $91.03 $3,842 - $4,551	-50 Reduced 0.36%	13,720 $1.24 Million
Q2 2024 Aug 02, 2024	BUY	$78.71 - $87.02 $55,884 - $61,784	710 Added 5.44%	13,770 $1.08 Million

Q1 2024 May 07, 2024	BUY	$82.84 - $88.09 $16,568 - $17,618	200 Added 1.56%	13,060 $1.14 Million
Q3 2023 Nov 03, 2023	BUY	$78.22 - $90.4 $78 - $90	1 Added 0.01%	12,860 $1.01 Million
Q2 2023 Jul 26, 2023	BUY	$79.47 - $91.38 $65,721 - $75,571	827 Added 6.87%	12,859 $1.13 Million
Q1 2023 May 02, 2023	SELL	$76.72 - $87.58 $24,857 - $28,375	-324 Reduced 2.62%	12,032 $970,000
Q4 2022 Feb 03, 2023	SELL	$76.18 - $87.74 $30,395 - $35,008	-399 Reduced 3.13%	12,356 $960,000
Q3 2022 Nov 07, 2022	BUY	$80.75 - $95.31 $88,986 - $105,031	1,102 Added 9.46%	12,755 $1.03 Million
Q2 2022 Aug 01, 2022	SELL	$87.4 - $113.09 $13,022 - $16,850	-149 Reduced 1.26%	11,653 $1.05 Million
Q1 2022 Apr 26, 2022	BUY	$100.58 - $112.38 $32,185 - $35,961	320 Added 2.79%	11,802 $1.31 Million
Q4 2021 Feb 01, 2022	BUY	$99.53 - $127.75 $597 - $766	6 Added 0.05%	11,482 $1.19 Million
Q3 2021 Nov 01, 2021	SELL	$122.75 - $135.17 $24,427 - $26,898	-199 Reduced 1.7%	11,476 $1.44 Million
Q2 2021 Aug 02, 2021	BUY	$118.19 - $131.5 $118 - $131	1 Added 0.01%	11,675 $1.45 Million
Q1 2021 Apr 30, 2021	SELL	$111.18 - $119.74 $24,904 - $26,821	-224 Reduced 1.88%	11,674 $1.38 Million
Q4 2020 Jan 29, 2021	BUY	$100.57 - $117.14 $10,157 - $11,831	101 Added 0.86%	11,898 $1.39 Million
Q3 2020 Oct 30, 2020	SELL	$90.13 - $108.78 $36,052 - $43,512	-400 Reduced 3.28%	11,797 $1.23 Million
Q2 2020 Aug 07, 2020	SELL	$84.11 - $103.33 $8,326 - $10,229	-99 Reduced 0.81%	12,197 $1.12 Million
Q1 2020 May 01, 2020	SELL	$72.92 - $121.3 $30,918 - $51,431	-424 Reduced 3.33%	12,296 $1.11 Million
Q4 2019 Jan 21, 2020	SELL	$104.49 - $114.54 $23,405 - $25,656	-224 Reduced 1.73%	12,720 $1.44 Million
Q3 2019 Nov 07, 2019	SELL	$98.02 - $111.18 $138,110 - $156,652	-1,409 Reduced 9.82%	12,944 $1.41 Million
Q2 2019 Jul 24, 2019	SELL	$84.15 - $99.38 $16,830 - $19,876	-200 Reduced 1.37%	14,353 $1.4 Million
Q1 2019 Apr 30, 2019	SELL	$82.45 - $93.79 $70,000 - $79,627	-849 Reduced 5.51%	14,553 $1.33 Million
Q4 2018 Feb 08, 2019	BUY	$85.8 - $99.49 $85 - $99	1 Added 0.01%	15,402 $1.4 Million
Q3 2018 Nov 05, 2018	BUY	$85.91 - $99.17 $8,676 - $10,016	101 Added 0.66%	15,401 $1.52 Million
Q2 2018 Aug 06, 2018	SELL	$77.48 - $87.83 $15,805 - $17,917	-204 Reduced 1.32%	15,300 $1.31 Million
Q1 2018 May 04, 2018	SELL	$76.55 - $87.26 $26,486 - $30,191	-346 Reduced 2.18%	15,504 $1.24 Million
Q4 2017 Feb 13, 2018	SELL	$76.93 - $83.5 $90,546 - $98,279	-1,177 Reduced 6.91%	15,850 $1.28 Million
Q3 2017 Nov 03, 2017	SELL	$77.71 - $84.6 $16,008 - $17,427	-206 Reduced 1.2%	17,027 $1.32 Million
Q2 2017 Aug 08, 2017	BUY	N/A	17,233	17,233 $1.53 Million

Others Institutions Holding MDT

# of Institutions

2,499

Shares Held

1.07B

Call Options Held

9.42M

Put Options Held

6.41M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $128B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account